Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report

Henrik H Rossing; Morten Grauslund; Edyta M Urbanska; Linea C Melchior; Charlotte Rask; Junia C Costa; Birgit G Skov; Jens Benn Sørensen; Eric Santoni-Rugiu

doi:10.1186/1756-0500-6-489

Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report

Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, Linea C Melchior, Charlotte Rask, Junia C Costa, Birgit G Skov, Jens Benn Sørensen, Eric Santoni-Rugiu

Department of Clinical Medicine

Research output: Contribution to journal › Journal article › Research › peer-review

40 Citations (Scopus)

Original language	English
Article number	489
Journal	BMC Research Notes
Volume	6
Issue number	December
Pages (from-to)	1-8
Number of pages	8
ISSN	1756-0500
DOIs	https://doi.org/10.1186/1756-0500-6-489
Publication status	Published - 2013

Access to Document

10.1186/1756-0500-6-489

Cite this

Rossing, H. H., Grauslund, M., Urbanska, E. M., Melchior, L. C., Rask, C., Costa, J. C., Skov, B. G., Sørensen, J. B., & Santoni-Rugiu, E. (2013). Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report. BMC Research Notes, 6(December), 1-8. [489]. https://doi.org/10.1186/1756-0500-6-489

Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib : a case report. / Rossing, Henrik H; Grauslund, Morten; Urbanska, Edyta M; Melchior, Linea C; Rask, Charlotte; Costa, Junia C; Skov, Birgit G; Sørensen, Jens Benn ; Santoni-Rugiu, Eric.

In: BMC Research Notes, Vol. 6, No. December, 489, 2013, p. 1-8.

Research output: Contribution to journal › Journal article › Research › peer-review

Rossing, HH, Grauslund, M, Urbanska, EM, Melchior, LC, Rask, C, Costa, JC, Skov, BG, Sørensen, JB & Santoni-Rugiu, E 2013, 'Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report', BMC Research Notes, vol. 6, no. December, 489, pp. 1-8. https://doi.org/10.1186/1756-0500-6-489

Rossing HH, Grauslund M, Urbanska EM, Melchior LC, Rask C, Costa JC et al. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report. BMC Research Notes. 2013;6(December):1-8. 489. https://doi.org/10.1186/1756-0500-6-489

Rossing, Henrik H ; Grauslund, Morten ; Urbanska, Edyta M ; Melchior, Linea C ; Rask, Charlotte ; Costa, Junia C ; Skov, Birgit G ; Sørensen, Jens Benn ; Santoni-Rugiu, Eric. / Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib : a case report. In: BMC Research Notes. 2013 ; Vol. 6, No. December. pp. 1-8.

@article{55fa2719e7fc4db3bef9f9f10d4c1de5,

title = "Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report",

author = "Rossing, {Henrik H} and Morten Grauslund and Urbanska, {Edyta M} and Melchior, {Linea C} and Charlotte Rask and Costa, {Junia C} and Skov, {Birgit G} and S{\o}rensen, {Jens Benn} and Eric Santoni-Rugiu",

year = "2013",

doi = "10.1186/1756-0500-6-489",

language = "English",

volume = "6",

pages = "1--8",

journal = "BMC Research Notes",

issn = "1756-0500",

publisher = "BioMed Central Ltd.",

number = "December",

}

TY - JOUR

T1 - Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib

T2 - a case report

AU - Rossing, Henrik H

AU - Grauslund, Morten

AU - Urbanska, Edyta M

AU - Melchior, Linea C

AU - Rask, Charlotte

AU - Costa, Junia C

AU - Skov, Birgit G

AU - Sørensen, Jens Benn

AU - Santoni-Rugiu, Eric

PY - 2013

Y1 - 2013

U2 - 10.1186/1756-0500-6-489

DO - 10.1186/1756-0500-6-489

M3 - Journal article

C2 - 24279718

VL - 6

SP - 1

EP - 8

JO - BMC Research Notes

JF - BMC Research Notes

SN - 1756-0500

IS - December

M1 - 489

ER -